d leucine

D-Leucine ((R)-Leucine) potently terminates seizures even after the onset of seizure activity. D-leucine reduces long-term potentiation but had no effect on basal synaptic transmission in vitro.

D-Leucine amide-CDDO-Me-HMP is a prodrug composed of CDDO-Me and ligustrazine. It serves a protective role against liver damage induced by CCl4. This compound can inhibit the production of reactive oxygen species (ROS), mitigate mitochondrial injury, and suppress apoptosis. Additionally, D-Leucine amide-CDDO-Me-HMP is applicable in liver injury research.

D-Leucine methyl ester hydrochloride is a useful organic compound for research related to life sciences. The catalog number is T66885 and the CAS number is 5845-53-4.

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-methylpentanoic acid is a useful organic compound for research related to life sciences. The catalog number is T65653 and the CAS number is 103478-63-3.

[D-Ala2]leucine-enkephalin acetate ([D-Ala2]leucine-enkephalin acetate (64963-01-5 free base)) is a delta opioid agonist used to study the signaling pathway of delta opioid receptors.

D-Leucine-D10 (Standard) is a reference standard of D-Leucine-D10 intended for quantitative analysis, quality control, and related biochemical research applications.

Prolylleucine (((Benzyloxy)carbonyl)-L-prolyl-D-leucine) is a dipeptide containing branched-chain amino acids.

NSC45586 is a protein phosphatase PHLPP inhibitor, which is selective for PHLPP1 and PHLPP2.

D,L-Cystathionine dihydrochloride is an intermediate in the synthesis of cysteine, which acts from the isotype of cysteine-β-synthase (CBS) produced by leucine and serine. Derived from cysteine. DL-cysteine contains a cysteine (βC-S) carbon-sulfur bond.

(R)-Leucic acid (D-HICA) is a leucine metabolite and an orally active D-isomer of the alpha-hydroxy leucine analogue. It promotes intestinal fatty acid absorption by upregulating CD36, used for lipid metabolism studies.

Diallyl G is a delta-opioid receptor antagonist agent.

β-D-Galactose pentaacetate, a negative regulator of insulin, possesses plasma membrane penetrating ability and can be hydrolyzed by intracellular esterases. It inhibits leucine-induced insulin release in Wistar rat islets, potentially preventing excessive insulin release in pathological conditions [1].

D-Galactose pentaacetate inhibits leucine-induced insulin release. It is used in research studies involving persistent hyperinsulinemia or insulinomas in children.

[D-Ala2]-Leucine enkephalin is a delta opioid agonist used to study the signaling pathway of delta opioid receptors.